Krane Funds Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437K | Buy |
9,449
+1,359
| +17% | +$62.9K | 0.02% | 76 |
|
|
2025
Q1 | $493K | Sell |
8,090
-998
| -11% | -$60.9K | 0.01% | 50 |
|
|
2024
Q4 | $514K | Sell |
9,088
-1,665
| -15% | -$94.2K | 0.02% | 39 |
|
|
2024
Q3 | $556K | Buy |
10,753
+829
| +8% | +$42.9K | 0.02% | 41 |
|
|
2024
Q2 | $412K | Sell |
9,924
-502
| -5% | -$20.8K | 0.02% | 62 |
|
|
2024
Q1 | $550K | Buy |
10,426
+5,038
| +94% | +$266K | 0.02% | 40 |
|
|
2023
Q4 | $276K | Sell |
5,388
-4,330
| -45% | -$222K | 0.01% | 87 |
|
|
2023
Q3 | $564K | Buy |
9,718
+795
| +9% | +$46.1K | 0.02% | 47 |
|
|
2023
Q2 | $571K | Buy |
8,923
+228
| +3% | +$14.6K | 0.03% | 45 |
|
|
2023
Q1 | $609K | Sell |
8,695
-183
| -2% | -$12.8K | 0.03% | 50 |
|
|
2022
Q4 | $639K | Sell |
8,878
-1,489
| -14% | -$107K | 0.03% | 44 |
|
|
2022
Q3 | $737K | Sell |
10,367
-110
| -1% | -$7.82K | 0.04% | 51 |
|
|
2022
Q2 | $807K | Sell |
10,477
-3,112
| -23% | -$240K | 0.03% | 58 |
|
|
2022
Q1 | $992K | Buy |
13,589
+7,143
| +111% | +$521K | 0.04% | 62 |
|
|
2021
Q4 | $402K | Sell |
6,446
-814
| -11% | -$50.8K | 0.01% | 174 |
|
|
2021
Q3 | $430K | Sell |
7,260
-10,436
| -59% | -$618K | 0.01% | 171 |
|
|
2021
Q2 | $1.18M | Buy |
17,696
+11,701
| +195% | +$782K | 0.04% | 67 |
|
|
2021
Q1 | $378K | Sell |
5,995
-4,574
| -43% | -$288K | 0.01% | 263 |
|
|
2020
Q4 | $656K | Buy |
10,569
+4,080
| +63% | +$253K | 0.03% | 118 |
|
|
2020
Q3 | $391K | Sell |
6,489
-158
| -2% | -$9.52K | 0.02% | 138 |
|
|
2020
Q2 | $391K | Sell |
6,647
-1,472
| -18% | -$86.6K | 0.02% | 120 |
|
|
2020
Q1 | $453K | Sell |
8,119
-763
| -9% | -$42.6K | 0.02% | 107 |
|
|
2019
Q4 | $570K | Buy |
+8,882
| New | +$570K | 0.04% | 93 |
|